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ABSTRACT: Spurred by the enormous interest in co-crystals from the pharmaceutical industry, 19 
many novel co-crystals of active pharmaceutical ingredients have been discovered in recent years 20 
and this has in turn led to an increasing number of reports on polymorphs of cocrystals. Hence, a 21 
thorough characterization and understanding of co-crystal polymorphs is a valuable step during 22 
drug development. The purpose of this study is to perform in situ structural analysis and to 23 
determine thermodynamic stability of a dimorphic co-crystal system, 1:1 caffeine-glutaric acid 24 
(CA-GA, Forms I and II). We performed thermal and structural characterizations by differential 25 
scanning calorimetry (DSC), thermogravimetric analysis (TGA), hot-stage microscopy (HSM), 26 
slurry and in situ variable temperature X-ray diffraction (VTXRD). For completeness, we have 27 
also re-determined crystal structures of CA-GA Forms I and II at 180 K using single crystal X-28 
ray diffraction. Our results revealed that Form II is stable and Form I is metastable at ambient 29 
conditions. Further, the results suggest that the dimorphs are enantiotropically related and the 30 
transition temperature is estimated to be 79 C.  31 
 32 
 INTRODUCTION 33 
Polymorphism is defined as the ability of a solid material to exist in at least two different 34 
crystal structures.
1-4
 Polymorph screening is a crucial part of the drug development process
1
 35 
because polymorphs exhibit different physicochemical properties, such as solubility, stability and 36 
bioavailability, the economic significance of novel polymorph as intellectual property is 37 
enormous.
1,2,4
 The high profile cases of ranitidine hydrochloride (Zantac) and ritonoavir (Norvir) 38 
serve to illustrate the importance of polymorphs to the pharmaceutical industry.
5
  It was believed 39 
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that only few multi-component crystals exist in polymorphic forms.
6
 However, as per McCrone, 40 
the number of solid forms known for a given compound is proportional to the time and money 41 
spent in research on that compound.
7,8
 Due to the interest of the pharmaceutical industry in co-42 
crystals, many novel co-crystals have been discovered in recent years and this has also led to an 43 
increasing number of reported cases of polymorphism in co-crystals.
9
 It was suggested that the 44 
number of co-crystal polymorphs that were reported after the year 2000 is significantly higher 45 
than the number of cocrystal polymorphs reported before. A recent database analysis in 2014
10
 46 
revealed that a total of 95 dimorphic, four trimorphic,
11-14
 three tetramorphic
10
 and one 47 
pentamorphic
15
 co-crystals have been reported. Interestingly, the percentage of polymorphs in 48 
cocrystals is comparable to the percentage of polymorphs in single-component crystals.
9
 Hence, 49 
a through characterization and understanding of polymorphs in co-crystal is as important as 50 
single-component crystals during drug development.  51 
Caffeine (1,3,7-trimethyl-2,6-purinedione), a central nervous system stimulant, is known 52 
to exhibit instability with respect to humidity with the formation of a crystalline 53 
nonstoichiometric hydrate.
16
 It is a popular model compound for pharmaceutical co-54 
crystallization studies.
17
 Jones et al., prepared a series of co-crystals involving caffeine and 55 
several dicarboxylic acids viz., glutaric acid, maleic acid, malonic acid and oxalic acid and 56 
demonstrated that they could be a remedy for caffeine hydration.
18
 Notably, the authors 57 
identified two polymorphic forms for the caffeine-glutaric acid (CA-GA, Forms I and II) from 58 
their liquid assisted grinding experiments and the two forms were structurally characterized. The 59 
CA-GA polymorphs varied in stability toward humidity - Form I transforms to Form II within 24 60 
h, and Form II is stable for over three days in high humidity condition before undergoing 61 
conversion to caffeine hydrate. Yu et al. have recently used attenuated total reflectance Fourier 62 
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transform spectroscopy (ATR-FTIR) and focused beam reflectance measurement (FBRM) to 63 
monitor and control co-crystallization of CA-GA in acetonitrile.
19,20
 The authors showed that by 64 
controlling the critical crystallization parameters, it is possible to eliminate the nucleation of 65 
undesirable Form I and produce considerably large particles with low proportion of fines. It has 66 
been found that in unseeded crystallization Form I nucleates first and then transforms to Form II.  67 
Seeding with Form II could avoid nucleation of Form I and produce only Form II. Recently, 68 
Thakuria et al., showed that atomic force microscopy can be used to distinguish the two 69 
polymorphs of the CA-GA co-crystal on the basis of the thickness of molecular layers of the two 70 
forms and they used this difference to monitor changes at the crystal surfaces during the 71 
transformation of Form I to Form II.
21
 Herein we report a thorough thermodynamic and in situ 72 
structural characterization study of 1:1 CA-GA co-crystal dimorphs (Scheme 1). 73 
 74 
Scheme 1. The chemical structures of (a) caffeine and (b) glutaric acid. 75 
 76 
 77 
 78 
 79 
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 EXPERIMENTAL SECTION 80 
Materials. Anhydrous caffeine (99% purity) was obtained from Fluka and glutaric acid (99%) 81 
from Alfa Aesar were used as received. The solvents were of analytical or chromatographic 82 
grade.  83 
Liquid Assisted Grinding (LAG).
22-26
 It was performed on a Retsch Mixer Mill model MM301 84 
with 10 mL stainless steel grinding jars and one 7 mm stainless steel grinding ball at a rate of 30 85 
Hz for 30 min. LAG screenings were carried out with stoichiometric amount of caffeine (1 86 
mmol) and glutaric acid (1 mmol) in several solvents. 50 μL of solvent was added to 200 mg of 87 
reactants mixture prior to LAG ( = 0.25 μL mg-1). The external temperature of the grinding jar 88 
at the end of grinding did not exceed 30 °C. The resulting powder samples were analyzed by 89 
PXRD. 90 
Solution Crystallization. Caffeine (1 mmol) and glutaric acid (1 mmol) were dissolved in 10 91 
mL of chloroform at 70 C. The solution was allowed to evaporate slowly at ambient conditions 92 
for two days to produce the concomitant dimorphs (colorless Form I needles and Form II blocks) 93 
of CA-GA co-crystal.
27
  94 
Powder X-ray Diffraction (PXRD). The powder diffraction data were collected in Bragg-95 
Brentano geometry with a Bruker D8 Advance (Bruker AXS GmbH, Germany) X-ray powder 96 
diffractometer equipped with a Cu-Kα radiation (λ = 1.54056 Å) source, a Nickel-filter, 0.3° 97 
divergence slit and a linear position sensitive detector (Vantec-1). The diffractometer was 98 
operated at 35 kV and 40 mA. The sample was loaded onto a glass circular sample holder of 1 99 
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mm thickness and 1.5 cm diameter. The data were collected over an angle range of 5 to 50° 2θ at 100 
a scanning speed of 2° 2θ per minute.  101 
Thermal Analysis. Thermogravimetric analysis (TGA) was conducted with a SDT 2960 102 
thermogravimetric analyzer (TA instruments). Approximately, 5 mg of sample was used per trial 103 
in an alumina crucible. The samples were heated at a rate of 10 °C/min from 25 to 275 °C. The 104 
samples were purged with a stream of flowing nitrogen throughout the experiment at 200 105 
mL/min. All samples were analyzed in duplicate. Differential scanning calorimetry (DSC) of all 106 
samples was performed using PYRIS Diamond DSC calorimeter (Perkin Elmer, USA). About 5 107 
mg of each sample was placed in a hermetically closed aluminum pan. The sample was heated 108 
from 25 to 120 °C at a rate of 10 °C/min after equilibrating the samples at 25 °C for 10 min. The 109 
samples were purged with a stream of flowing nitrogen at 25 mL/min. 110 
 111 
Hot-stage Microscopy (HSM). Thermomicroscopic investigations were performed with an 112 
optical polarizing microscope (Olympus, BX51, Olympus Optical GmbH, Vienna) equipped 113 
with a Linkam hot-stage THMS 600 connected to a TMS 94 temperature controller and a LNP 114 
94/2 liquid nitrogen pump (Linkam Scientific Instruments Ltd, Tadworth, Surrey, UK). The 115 
microscopic images were recorded with a CCD camera attached to the microscope at 12 s time 116 
interval using Soft Imaging System’s Analysis image capture software. Caffeine-glutaric acid 117 
Forms I and II were heated over the temperature range of 25-110 C at a constant heating rate of 118 
10 C min1 and cooled back to room temperature. The hot-stage was calibrated using USP 119 
melting point standards. 120 
 121 
7 
 
Single Crystal X-ray Diffraction. Single crystals of caffeine-glutaric acid Forms I and II were 122 
chosen under a Leica microscope and placed on a fibre needle which was then mounted on the 123 
goniometer of the X-ray diffractometer. The crystal was purged with a nitrogen gas stream at 180 124 
K throughout the data collection. X-ray reflections were collected on a Rigaku Saturn CCD area 125 
detector with graphite monochromated Mo-Kα radiation (λ = 0.71073 Å). Data were collected 126 
and processed using CrystalClear (Rigaku) software. The crystal structures were solved by direct 127 
methods and SHELX-TL was used for structure solution and least-squares refinement.
28
 All 128 
hydrogen atoms were fixed at idealized positions except for the acid O–H hydrogens, which 129 
were located from the difference Fourier map and allowed to ride on their parent atoms in the 130 
refinement cycles. All O–H and C−H distances are neutron normalized to 0.983 and 1.083 Å, 131 
respectively. Data collection and refinement details are given in Table 2, and the relevant 132 
hydrogen bonding interactions and their geometries are listed in Table 3. 133 
 134 
Variable Temperature X-ray Diffraction (VTXRD). The data were collected in asymmetric 135 
reflection geometry using an Inel Equinox 3000 diffractometer (INEL, Artenary, France) 136 
equipped with a Cu-Kα source, a NiC multilayer Goebel mirror, an XRK-900 reactor chamber 137 
(Anton Paar GmbH, Graz, Austria) and a CPS-250 position sensitive detector (INEL, Artenay, 138 
France). The diffractometer was operated at 30 kV and 30 mA. All data were collected over 139 
angle range of 4 to 105 2θ  in air at an incident beam angle of 5.  140 
Approximately 100 mg of caffeine-glutaric acid Form II was filled into a sample holder 141 
by the top-fill technique and heated from 25 to 98 C at a rate of 1 C/min. The sample was held 142 
at 98 C for 70 min. Subsequently, the sample was cooled to 25 C at a rate of 1 C/min. 143 
Quantitative analysis of solid-state transformation of Form II to Form I during heating ramp was 144 
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performed by Rietveld refinements using Topas v4.2 (Bruker-AXS GmbH, Karlsruhe, 145 
Germany). The peak shape was modeled by a convolution of a square function with a Lorentzian 146 
function, a Gaussian function and a circles function. Our re-determined single crystal structures 147 
of Forms I and II were used as structure models. The semiquantitative analysis of the melting 148 
process was also conducted by the Rietveld refinement. The structure published by Lehmann et 149 
al., was used as model for caffeine.
29
  150 
Similarly, ~100 mg of caffeine-glutaric acid Form I was heated from 25 to 95 C and 151 
held at 95 C for 45 min and cooled back to 25 C. For both the heating and cooling ramps, the 152 
rates employed were 1 C/min.  153 
 154 
 RESULTS AND DISCUSSION 155 
LAG experiments were conducted in 13 solvents and the product phases were analyzed by 156 
PXRD (Table 1). The results complemented well with the reported LAG experiments that the 157 
outcome is dependent on the polarity of solvent.
27
 Herein polar solvents favored the formation of 158 
CA-GA Form II whereas in diethyl ether a mixture of CA-GA Forms I and II was obtained.  159 
 160 
 161 
 162 
 163 
 164 
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Table 1. The Outcome of Liquid Assisted Grinding of a 1:1 Molar Ratio of Caffeine and 165 
Glutaric Acid with Various Solvents. 166 
 167 
Liquid  Cocrystal form as 
identified by PXRD 
a
cyclohexane, heptane, n-hexane  Form I 
 
a
chloroform, dichloromethane, acetonitrile, 
water 
 
Form II 
1,4-dioxane, toluene, mesitylene, anisole, 
ethylacetate, tetrahydrofuran, isopropanol, 
acetone, methanol, nitromethane, 
dimethylformamide, dimethylsulfoxide   
  
Form II 
diethyl ether Forms I + II 
a
Presented in previous studies, see reference # 15. 168 
Solution Crystallization  169 
Evaporative co-crystallization of equimolar CA and GA from chloroform at ambient conditions 170 
afforded the concomitant dimorphic co-crystals (Form I and Form II) of CA-GA.
27
 Due to the 171 
distinct shapes of the two forms, single crystals of each form could be easily picked out manually 172 
by visual observation.   173 
Crystal Structure Analysis  174 
The crystal structures of CA-GA dimorphs have been reported previously by Jones and co-175 
workers.
18, 27
 To facilitate a comparison of crystal packing and thermodynamic stabilities of CA-176 
GA Forms I and II, single crystal X-ray diffraction at 180K were also performed for these 177 
dimorphs. Crystallographic parameters and hydrogen bonding geometries for CA-GA Forms I 178 
and II are provided in Tables 2 and 3.  179 
 180 
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Table 2. Crystallographic Data for Dimorphs of 1:1 Caffeine-Glutaric Acid.  181 
 Form I Form II 
Empirical formula (C8H10N4O2)·(C5H8O4) 
Formula weight 326.31 
Crystal system Monoclinic  Triclinic 
Space group P 21/c P
-
1 
T [K] 180(2) 180(2) 
a [Å] 12.989(3) 8.3273(17) 
b [Å] 6.5994(13) 8.6640(17) 
c [Å] 17.118(3) 11.362(2) 
 [] 90.00 68.96(3) 
 [] 97.84(3) 78.54(3) 
 [] 90.00 74.22(3) 
Z 4 2 
V [Å
3
] 1453.6(5) 731.6(3) 
Dcalc [g cm
-3
] 1.491 1.481 
 [mm-1] 0.119 0.119 
Reflections used 8749 8039 
Unique reflections 2505 2546 
Observed reflections 2114 2438 
Parameters 212 216 
R1[I > 2σ(I)] 0.1047 0.0576 
wR2 [all]  0.2921 0.1594 
GOF  1.199 1.087 
Crystal shape Needle Block 
 182 
The morphologies of the CA-GA co-crystal polymorphs (Forms I and II) were distinctly 183 
different under the optical microscope i.e. needle-shaped crystals for Form I, block-shaped 184 
crystals for Form II. Form I crystallized in P21/c while Form II in P
-
1 space group. The 185 
asymmetric units of either Form I or II consist of 1:1 stoichiometry of caffeine and glutaric acid 186 
molecules. Two dimensional crystal packing of the dimorphs shows similar hydrogen bond tapes 187 
where linear OH···O synthons are present between the OH groups of one glutaric acid and the 188 
C=O of the adjacent glutaric acid.  The other acid O-H groups of glutaric acid are connected to 189 
the imidazole ring of caffeine via OH···N hydrogen bond to form layers (Figure 1). The 190 
alignments of molecules are slightly different in each of the polymorph meaning Form I consists 191 
of a flat layer whereas a corrugated layer can be seen in case of Form II. We plotted the overlay 192 
diagram of caffeine and glutaric acid molecules across Forms I and II (Figure 2). It depicts that 193 
11 
 
there is no appreciable change in the molecular conformations within caffeine (except for methyl 194 
C-H orientations) or glutaric acid molecules (Figure 2).     195 
 
 
Figure 1. Crystal packing of CA-GA co-crystal dimorphs, Forms I and II. Note that these 196 
dimorphs are stabilized by similar sheet structures composed of hydrogen bonded ribbons. 197 
 
 
 
 
Figure 2. Overlay of conformers of CA (left) and GA (right) in Forms I and II. Color codes: 198 
Form I – green and Form II – pink.  199 
 200 
a 
0 c 
b 
(A) Form I (B) Form II 
a 
0 
c 
b 
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Table 3. Hydrogen Bond Geometries for 1:1 Caffeine-Glutaric Acid Polymorphic Forms I 201 
and II. 202 
CA-GA D–HA d(HA)/ Å d(DA)/ Å ( D–HA)/            
Form I O–HN 1.75 2.719(5) 169 
 O–HO 1.74 2.721(4) 177 
 C–HO 2.19 3.140(5) 145 
 C–HO 2.37 3.347(5) 150 
 C–HO 2.46 3.193(5) 124 
 C–HO 2.58 3.320(5) 125 
 C–HO 2.64 3.525(5) 139 
 C–HO 2.66 3.670(5) 155 
 C–HO 2.68 3.571(5) 139 
        intra C–HO 2.27 2.743(6) 104 
        intra C–HO 2.23 2.732(6) 106 
Form II O–HN 1.73 2.716(2) 177 
 O–HO 1.78 2.751(2) 171 
 C–HO 2.19 3.138(3) 145 
 C–HO 2.37 3.430(3) 166 
 C–HO 2.41 3.377(3) 148 
 C–HO 2.48 3.202(3) 123 
 C–HO 2.53 3.213(3) 120 
 C–HO 2.68 3.543(3) 137 
        intra C–HO 2.19 2.698(3) 106 
        intra C–HO 2.45 2.940(3) 106 
O–H and C–H geometries are neutron normalized to 0.983 and 1.083 Å. D = donor, A= acceptor. 203 
 204 
Thermal Analysis. Differential scanning calorimetry (DSC) and thermogravimetric analysis 205 
(TGA) were carried out for Forms I and II of CA-GA co-crystal (Figure 3 and see also Figure S1 206 
of Supporting Information, SI). Form I showed one major endotherm with Tonset at 98.8 C (heat 207 
of fusion, Hf, 118 J g
1
) that is attributed to a melting event. In the case of Form II, two 208 
endotherms were observed. A minor endotherm (peak Tonset at 93.8 C, 3.4 J/g) could be 209 
interpreted broadly as a phase transformation of Form II to Form I. But, a detailed analysis, an 210 
inset view of Form II (Figure 3), suggests that the solid-solid phase transition of Form II to Form 211 
I can be seen to occur well before a minor endotherm, which is with Tonset at 78.6 C (6.7 J g
1
), 212 
whereas a major endotherm with Tonset at 98.5 C (106 J g
1
) corresponding to melting of Form I. 213 
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TGA traces of CA-GA Forms I and II showed the absence of solvent molecules in these 214 
crystalline phases (Figure S1, SI). The weight loss occurred past 150 C is attributed to 215 
degradation.      216 
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Figure 3. DSC trace for CA-GA polymorphic forms, Forms I and II. The inset view of Form II 217 
suggests that with Tonset at 78.6 C (6.7 J g
1
) could be ascribed as solid-solid phase 218 
transformation of Form II to Form I.  219 
 220 
Hot-Stage Microscopy (HSM)  221 
The thermal events observed in the DSC/ TGA experiments on CA-GA Forms I and II were 222 
visualized using HSM. The photomicrographs in Figure 4 show the snapshot images of the 223 
crystals at various temperatures during the experiments. These dimorphs were heated from RT to 224 
110 °C and cooled back to RT at a rate of 10 C/min. The HSM results agree well with the DSC 225 
results.    Melting of Form II was observed to begin from around 98 
o
C as evidenced from the 226 
rounding of the edge of the crystal. The transformation from Form II to Form I before melting 227 
could not be clearly observed but careful examination of the photomicrographs revealed the 228 
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appearance of small needle-shaped Form I on the surface of the Form II crystal from around 90 229 
o
C (Figure 5).  The transformation of Form II to Form I then took place concurrently with 230 
melting.  Upon cooling to RT, only Form I remained. For Form I, no change in morphology was 231 
observed before melting and only Form I was observed after cooling to RT.  232 
Heating Cooling  Heating Cooling 
 
25 C 
 
102 C 
 
 
25 C 
 
103 C 
 
98 C 
 
80 C 
 
99 C 
 
81 C 
 
102 C 
 
58 C 
 
103 C 
 
57 C 
 
110 C 
 
25 C 
 
110 C 
 
25 C 
(a) Caffeine-glutaric acid Form II.  (b) Caffeine-glutaric acid Form I. 
 233 
Figure 4. Photomicrographs of 1:1 caffeine-glutaric acid co-crystal polymorphic forms, (a) Form 234 
II and (b) Form I, respectively extracted from the HSM experiments. 235 
 236 
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 237 
Figure 5. Nucleation and growth of needle-shaped Form I CA-GA cocrystal on the surface of 238 
Form II crystal during the HSM experiment.  The red oval marks the location of one of the Form 239 
I crystals observed and its evolution in size with time as heating proceeded.  240 
 241 
Variable Temperature X-ray Diffraction (VTXRD) 242 
VTXRD was performed for CA-GA co-crystal dimorphs, Forms I and II, independently to 243 
understand in situ phase changes. Firstly, CA-GA Form II was subjected to the VTXRD from 25 244 
C to 98 C at a heating rate of 1 C/min, held at 98 C for 60 min and cooled to 25 C at a 245 
heating rate of 1 C/min. The in situ phase changes were analyzed by means of a powder pattern 246 
taken every minute during the entire study. The heating rate employed was chosen to be much 247 
slower than that used in DSC analysis (10 
o
C/min) because the interval between each PXRD 248 
pattern acquisition was one minute so a slower rate would allow more detailed examination of 249 
the phase change at different temperature. Due to the slower heating rate, the phase 250 
transformation is expected to occur at a lower temperature compared to in the DSC because the 251 
system has more time to attain thermodynamic equilibrium at a slower heating rate. The VTXRD 252 
patterns were compared with that of pure CA-GA Forms I and II and also with that of caffeine 253 
itself (Figure 6 and see also Figure S2, SI). As per the PXRD patterns, Form II was intact from 254 
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25 C to 68 C. Notably, Form I started to appear from 69 C alongside a major phase of Form 255 
II. The complete conversion of Form II to I was observed by 85 C. Form I was intact from 85 to 256 
98 C and it melted upon being held for 2 min at 98 C. The powder pattern of the melt phase 257 
matched to that of pure caffeine, indicating that some of the CA-GA co-crystal has dissociated 258 
into caffeine and gluartic acid. While glutaric acid phase (mp 95-98 C) melted, the higher 259 
melting caffeine (mp 235-238 C) remained in its solid form alongside the remaining solid Form 260 
I.  During the rest of the holding period of 58 min at 98 C, all Form I melted leaving behind 261 
solid caffeine and liquid glutaric acid. Upon cooling from 98 C to 78 C, Form I nucleated and 262 
further cooling led to the growth of this crystalline phase. As shown in Fig. 6, Form I phase 263 
remained even at 25 C (See also Figure S2, SI). 264 
17 
 
10 20 30 40
0
6000
12000
18000
24000
30000
36000
42000
48000
54000
60000
C
o
o
lin
g
H
e
a
ti
n
g
, 
1
0
C
/m
in
25
0
C
50
0
C
70
0
C
78
0
C
79
0
C
 2 min held at 98
0
C
98
0
C
85
0
C
79
0
C
75
0
C
69
0
C
68
0
C
60
0
C
50
0
C
30
0
C
Form II
Form I
In
te
n
s
it
y
 (
a
rb
it
ra
ry
 u
n
it
s
)
2
Caffeine
 265 
Figure 6. Variable temperature X-ray diffraction of caffeine-glutaric acid Form II from 25 C to 266 
98 C at a heating rate of 1C/min, held at 98 C for 60 min and subsequently cooled to 25C at a 267 
heating rate of 1C/min. Note a start of phase change of Form II to Form I at 69 C and 268 
exclusively Form I could be observed by 85 C. Form I remained until 98 C and melted upon 269 
being held for 2 min at that temperature. Upon cooling to 78 C, Form I nucleated and was the 270 
only phase observed at the end of the cooling process at 25 
o
C. 271 
 272 
The quantitative analysis of the solid-state transformation of Form II to Form I during the 273 
heating ramp was performed by Rietveld refinements using Topas v4.2 (Bruker-AXS GmbH, 274 
Karlsruhe, Germany).  The peak shape was modeled by a convolution of a square function with a 275 
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Lorentzian function, a Gaussian function and a circles function. Our re-determined single crystal 276 
structures of Forms I and II were used as structure models. Rietveld refinements show that the 277 
conversion of Form II to I of CA-GA co-crystal occurred between 65 C and 85 C (Figure 7). 278 
Note the onset of phase transformation was observed at 66 °C, which is earlier than expected 279 
from the visual inspection of the powder patterns. At 79 C, Form II and I exist in equal amount. 280 
 281 
 282 
Figure 7. Reitveld refinements show that the conversion of Form II to Form I of CA-GA co-283 
crystal occurred between 65 C and 85 C. Note the onset of phase transformation was observed 284 
at 66 °C, which is earlier than expected from the visual inspection of the powder patterns. At 79 285 
C, Form II and I exist in equal amounts. 286 
 287 
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The semi-quantitative analysis of the melting process was conducted using a combination 288 
of Rietveld refinement (to monitor the relative abundance of the crystalline phases) with the 289 
Degree of Crystallinity Method to estimate the amorphous content. The structure published by 290 
Lehmann et al. was used as model for caffeine.
29 
The melting process can be observed between 291 
97 and 98 °C. Most of it occurs during the first 2 minutes of the holding time at 98 °C (Figure 8). 292 
It should be noted that Figure 8 only captures the relative abundances of the two crystalline 293 
phases, co-crystal Form I and caffeine. The amorphous (melt) content is not considered in this 294 
figure. Form I was removed from Rietveld refinements when no unique peaks were observed. 295 
The strongest peak of Form I overlaps with a strong caffeine reflection and simple visual 296 
observation of the PXRD patterns could easily mistake caffeine as Form I. The evolution of 297 
amorphous content is shown in Figure 9. For this method the background was fixed to the values 298 
obtained from a refinement just before the onset of melting at 97 °C. The amorphous phase 299 
was modelled using two Split pseudo-Voigt peaks at 8.7 and 23.4° respectively while the 300 
crystalline phases were matched with a series of narrow peaks. The areas below these two peak 301 
series were integrated and the breakdown in crystalline and amorphous area gave the degree of 302 
crystallinity. The crystalline phase remaining after the first three minute corresponds to 303 
crystalline caffeine (Figure 8).  304 
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 305 
Figure 8. Reitveld refinement shows the conversion of Form I CA-GA co-crystal to caffeine 306 
occurred between 0-3 min of holding time at 98 C.  307 
 308 
 309 
Figure 9. Evolution of amorphous content during melting process.  310 
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Next, CA-GA Form I was subjected to VTXRD from 25 C to 95 C at a heating rate of 1 311 
C/min and held at 95 C for 45 min and cooled to 25 C at a cooling rate of 1 C/min.  The 312 
powder patterns were analyzed for any in situ phase changes (Figure 10 and see also Figure S3, 313 
SI). It reveals that Form I remained unchanged throughout the experiment. The result is in 314 
agreement with DSC and HSM results (Figures 3 and 4).  315 
 316 
 317 
Figure 10. Variable temperature X-ray diffraction of caffeine-glutaric acid Form I. No phase 318 
change was observed during heating ramp from 25 C to 95 C at 1 C/min heating rate. 319 
 320 
 321 
 322 
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Thermodynamic Stability 323 
In this part, we aim to understand the stability relationships of Forms I and II. Thermal analysis 324 
and in situ X-ray diffraction formed an excellent basis for the construction of a qualitative energy 325 
vs temperature diagram (Figure 11).  The physical properties of the CA-GA polymorphs are 326 
given in Table 4. The heat of fusion value for Form II was estimated using Hess’s law of heat 327 
summation
30
 (Hf+Ht) as no direct melting was observed for Form II. From our DSC analysis, 328 
the phase transition from Form II to Form I is endothermic.  According to heat of transition 329 
rule,
31,32
 the dimorphs of CA-GA co-crystal are enantiotropically related. VTXRD heat-cool 330 
studies suggested that these enantiotropic dimorphs are irreversible in the employed conditions 331 
that Form I was not observed to transform to Form II upon cooling.  However, given time, CA-332 
GA Form I would transform to Form II in solid state but the solid-state transformation rate 333 
depends on the environment that the crystals are in, which ranges from less than a day at high 334 
humidity to over weeks at 0% RH.
18
 In any case their free energies become equal at the transition 335 
temperature Tp
III
. From in situ VTXRD information we estimate that the transition temperature 336 
could be at 79 C. Enantiotropic transitions are by definition thermodynamically reversible with 337 
temperature and pressure.
33,34
 To gain further understanding of the CA-GA dimorphs, DSC heat-338 
cool-heat studies were performed for Form II where Form II was heated from room temperature 339 
to melting and the melt was cooled to below room temperature i.e. -5 C and then the sample 340 
was heated until its melting point at 10 C/min heating rate (Figure S4, SI). As expected, heating 341 
cycle 1 results were similar to DSC events shown in Figure 3 whereas heating cycle 2 profile 342 
resembled by and large heating cycle 1 results meaning there was a solid-state conversion of 343 
Form II to Form I phase that was followed by melting event. The results indicate that upon 344 
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heating cycle 1, i.e. during cooling of the melt, Form I was formed (see also VTXRD results) and 345 
the phase was retained until room temperature, however, further cooling to -5 C led to the solid-346 
state phase transformation of Form I to II. Hence, DSC heat-cool-heat results suggest that CA-347 
GA dimorphs are enantiotropically related. Herein the enantiotropic reversible conversion has 348 
been noted with hysteresis, meaning cooling beyond room temperature was required in 349 
accordance with findings elsewhere.
33-34
 350 
Slurry transformation studies
35
 are a practical way to determine the thermodynamic 351 
stabilities of different solid forms. A 50%+50% (w/w) mixture of Forms I and II were added to 352 
acetonitrile and stirred at ambient conditions for 24 h. The analysis of PXRD and DSC of the 353 
product phase indicated that Form I had transformed to Form II. This result confirmed that the 354 
Form II is thermodynamically stable form and Form I is metastable at the ambient conditions.  355 
 356 
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Figure 11. Energy versus temperature (ET) diagram of an enantiotropic dimorphic cocrystal of 357 
caffeine-glutaric acid: G = Gibbs free energy, H = enthalpy, liq = liquid phase, Tp= transition 358 
point and Tf = melting temperature.  359 
 360 
The calculated densities and packing fractions were obtained from the single crystal 361 
structures determined at 180 K (Table 4). The density and packing fraction of Form I are higher 362 
than those of Form II which is in contrary to the density rule that a polymorph with a lower 363 
density is metastable and a polymorph with a higher density is stable at room temperature.
32
 But, 364 
exceptions to the density rule are reported in literature.
36-38
 Density rule could be more applicable 365 
to the molecular crystals where van der Waals interactions are predominantly involved in the 366 
crystalline lattice.
1
 In cases where hydrogen bonding interactions play a significant role, such as 367 
with CA-GA Forms I and II, density rule may not be strictly followed.      368 
 369 
Table 4. Physical Properties of Caffeine-Glutaric Acid Polymorphs, Forms I and II. 370 
Modification Form I Form II 
M.p. (C) (DSC onset temperature) 98.8 - 
Tp (
o
C) (DSC onset temperature) - 78.6 
Heat of fusion, Hf/ J g
−1
 118 124.7
a
 
Heat of transition, Ht/ J g
-1
  6.7 
Density (g cm
−3
) 1.491 1.481 
Packing coefficient (Ck*) 74.0 73.5 
   
Stability at 25 C Metastable Stable 
a
 Calculated by Hess’s law of heat summation 371 
  372 
 373 
 374 
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 CONCLUSIONS 375 
In conclusion, the dimorphs, Forms I and II, of 1:1 caffeine-glutaric acid cocrystal were 376 
unequivocally characterized by LAG, thermal, single crystal and in situ X-ray diffraction and 377 
slurry transformation studies. LAG in polar solvents favored the formation of Form II. Thermal 378 
(DSC TGA and HSM) and slurry studies suggest that Form II is thermodynamically stable and 379 
Form I is metastable at ambient conditions and they are enantiotropically related. VTXRD results 380 
reveal interesting insights about the thermal behavior of these dimorphs. Form II converted to 381 
Form I at an onset temperature of 66 C and pure Form I was observed by 85 C which then 382 
melted at ~98C.  Upon cooling, Form I nucleated at 78 C and was the only form observed at 383 
the end of the cooling process at 25
o
C.  Rietveld analysis showed that the transition temperature 384 
for this dimorphic pair could be at 79 C where both forms were found to be present in equal 385 
proportion. On the other hand, VTXRD of Form I showed no phase changes throughout the 386 
experiment.  It should be noted that Form I transformed to the thermodynamically stable Form II 387 
with hysteresis at temperature below the transition point during cooling suggesting that the CA-388 
GA dimorphs Forms I and II are enantiotropically related.  A schematic energy-temperature 389 
diagram was constructed for the two polymorphs based on the results obtained.  390 
 391 
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1402961 contain the supplementary crystallographic data for this paper. This information is 396 
available free of charge via the Internet at http://pubs.acs.org/ . 397 
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Figure S1. TGA trace of for CA-GA polymorphic forms, Forms I and II. Note the absence of 
solvent molecules in these crystalline phases. 
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Figure S2. Variable temperature X-ray diffraction patterns of caffeine-glutaric acid Form II are 
shown in details.  
 
(a) 3D plot showing the events occurred 
during heating from 25 C to 98 C at 
the heating rate of 1 C/min. Note the 
phase change of Form II to Form I.  
 
(b) Holding ramp at 98 C for 60 min. 
Note that Form I melts within the first 
2 minutes. The observed crystalline 
phase after the melting matches to that 
of pure caffeine.  
 
 
(c) 2D plot of cooling ramp from 98C to 25 C 
at the heating rate of 1 C/min. Notice the 
phase change of caffeine to Form I, caffeine-
glutaric acid co-crystal, at 78 C. 
 
 
(d) 3D plot of cooling ramp from 98C to 
25 C at the heating rate of 1 C/min. 
Notice the phase change of caffeine to 
Form I, caffeine-glutaric acid co-
crystal, at 78 C. 
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Figure S3. Variable temperature X-ray diffraction of caffeine-glutaric acid Form I from 25 C to 
95 C at 1 C/min. Next, it was held at 95 C for 45 min. Subsequently, the sample was cooled to 
25 C at 1 C/min.  
 
 
(a) 2D plot shows that there were no phase 
changes occurred during heating ramp. 
 
 
(b) 2D plot shows that there were no phase 
changes during holding ramp. 
 
 
(c) 2D plot depicts that there were no phase 
changes occurred during cooling ramp. 
 
 
  
S5 
 
Figure S4. DSC heat-cool-heat profiles of CA-GA Form II at 10 C/min heating rate. Heating 
cycle 1 involved heating of sample from room temperature to 170 C and the melt was subjected 
to cooling cycle 1 (170 C  to -5 C) , which was followed by heating cycle 2 (-5C to 170 C). 
The heating cycle 2 results suggest that Form II transformed to Form I during heating followed 
by melting of Form I at 98.2 C which indicates that during cooling cycle 1, initially Form I was 
formed (VTXRD results support this) and upon further cooling to -5 C, Form I could have 
converted to Form II. Hence, CA-GA dimorphs, Forms I and II, are enantiotropically related.  
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